AllPennyStocks.com Small Cap Finds Mid-Week Success On Dual Announcement

Small Cap Finds Mid-Week Success On Dual Announcement

Small Cap Finds Mid-Week Success On Dual Announcement By: Dylan Sikes – AllPennyStocks.com News

Wednesday, January 22, 2025

A Washington State-based biotech found quite a bit of success on Wednesday after Needham & Co. initiated coverage with a Buy rating and a $9 price target. This news came just as the company announced that it will participate in the Guggenheim Securities SMID Cap Biotech Conference.

Traders were quick to buy up shares of Absci Corporation (Nasdaq:ABSI), pushing the small cap up to close up at $4.03/share (+25.16%). This rally was a strong continuation of yesterday’s success, and could be a catalyst for this stock in the near future.

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.


Copyright © 2025 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

New Crypto Strategy Has This Micro-Cap’s Shares Gaining Value
Small Cap Finds Mid-Week Success On Dual Announcement
This Biotech Soared On Wednesday Following AI-Related Announcement
Most Popular


Back to Top